The BC Cancer Agency is committed to reducing the incidence of cancer, reducing the mortality from cancer, and improving the quality of life of those living with cancer. BC Cancer Agency provides a comprehensive cancer control program for the people of British Columbia in partnership with regional health authorities to deliver a range of cancer services, which include prevention, screening and early detection, diagnosis and treatment, research, education, supportive care, rehabilitation and palliative care. It operates six regional cancer centres in Surrey, Kelowna, Vancouver, Victoria, Abbotsford, and Prince George.
BCCA is an agency of the Provincial Health Services Authority (PHSA) which plans, manages and evaluates specialty and province-wide health care services across BC. PHSA embodies values that reflect a commitment to excellence. These include: Respect people • Be compassionate • Dare to innovate • Cultivate partnerships • Serve with purpose.
The University of British Columbia (UBC) is Canada’s third largest university and consistently ranks among the 40 best universities in the world. Primarily situated in Vancouver, UBC is a research-intensive university and has an economic impact of $4 billion to the provincial economy.
Faculty Position – Clinician Scientist
Regular (Permanent) Full Time Opportunity
Compensation: $277,969 to $347,461 per annum plus benefits
Hours of work: 37.5 hours per week plus week nights and weekends rotation/on-call services
The Leukemia and Bone Marrow Transplant Program of BC
Terry Fox Laboratory, BC Cancer Agency
675 West 10th Avenue
Vancouver, BC V5Z 1L3
Applications are invited from outstanding hematologists for a new Clinician Scientist faculty position, jointly appointed in the Terry Fox Laboratory (TFL) and the Leukemia/Bone Marrow Transplant Program (L/BMT) of the BC Cancer Agency (BCCA). The TFL is an academic research department representing an interdisciplinary and highly collaborative group with a mix of clinical and/or basic training expertise and a long track record in hematopoiesis and leukemia, immunology, technology development and genome control mechanisms. The L/BMT program is a FACT accredited stem cell transplantation program that currently transplants approximately 200 patients per year. The L/BMT provides care for autologous and allogeneic transplant recipients (including related, unrelated and cord blood transplants) and for acute leukemia patients in the Province of BC.
The preferred applicant shall have experience beyond Fellowship training and have expertise in both BMT and hematologic malignancies. In addition, the successful candidate should have a track record of research excellence and a keen interest in clinical and basic cancer research. With the support of the TFL and L/BMT program the applicant will be expected to establish a competitive research program (50% protected research time) that makes high quality contributions to hematological malignancies on an international stage, attracts peer reviewed funding and strengthens our excellent training environment. The new position is targeted preferentially (but not exclusively) at an early-stage career candidate whose research program will complement the present faculty and fit BCCA’s mission to reduce the incidence of cancer, to reduce the mortality rate of people with cancer, and to improve the quality of life of people living with cancer.
The successful applicant must have an M.D. or M.D./Ph.D., be eligible for licensure by the BC College of Physicians & Surgeons, and an appropriate academic appointment through the University of British Columbia. Interested candidates should send: 1) a curriculum vitae; 2) contact information for 3 references; and 3) a 2-3 page statement outlining the applicant’s clinical and research interests, achievements and future goals. Send all documents by PDF in one file to:
Senior Director, Research Administration and Operations
Office of the Vice-President, Research
We will be reviewing applicants upon receipt and will continue until the position is filled.
Expected start date of the appointment is July 1, 2018 or a mutually agreed upon date.
Generous benefits package included. May be eligible for relocation.
Please see www.terryfoxlab.ca and www.leukemiabmtprogram.org for more information.
PHSA and UBC hire on the basis of merit and are committed to employment equity. We encourage all qualified persons to apply; however, Canadians and permanent residents of Canada will be given priority. English is the official language used at PHSA.